Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles

[1]  J. Willmann,et al.  Quantitative Assessment of Inflammation in a Porcine Acute Terminal Ileitis Model: US with a Molecularly Targeted Contrast Agent. , 2015, Radiology.

[2]  Fabian Kiessling,et al.  Recent advances in molecular, multimodal and theranostic ultrasound imaging. , 2014, Advanced drug delivery reviews.

[3]  F. Kiessling,et al.  Ultrasound Molecular Imaging of E-Selectin in Tumor Vessels Using Poly n-Butyl Cyanoacrylate Microbubbles Covalently Coupled to a Short Targeting Peptide , 2013, Investigative radiology.

[4]  F. Kiessling,et al.  Rhodamine-Loaded Intercellular Adhesion Molecule–1-targeted Microbubbles for Dual-Modality Imaging Under Controlled Shear Stresses , 2013, Circulation. Cardiovascular imaging.

[5]  G. Schmitz,et al.  Reconstruction of flow velocity inside vessels by tracking single microbubbles with an MCMC data association algorithm , 2013, 2013 IEEE International Ultrasonics Symposium (IUS).

[6]  J. Willmann,et al.  Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. , 2013, Radiology.

[7]  F. Kiessling,et al.  The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55) , 2013, European Radiology.

[8]  Sadik C Esener,et al.  Aptamer‐Crosslinked Microbubbles: Smart Contrast Agents for Thrombin‐Activated Ultrasound Imaging , 2012, Advanced materials.

[9]  F. Kiessling,et al.  Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment. , 2012, European journal of radiology.

[10]  J. Willmann,et al.  Ultrasound Molecular Imaging Contrast Agent Binding to Both E- and P-Selectin in Different Species , 2012, Investigative radiology.

[11]  M. Arditi,et al.  Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent. , 2012, Ultrasound in medicine & biology.

[12]  F. Kiessling,et al.  Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics. , 2012, Current pharmaceutical design.

[13]  Paul A Dayton,et al.  An in vivo validation of the application of acoustic radiation force to enhance the diagnostic utility of molecular imaging using 3-d ultrasound. , 2012, Ultrasound in medicine & biology.

[14]  Fabian Kiessling,et al.  Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics , 2012, The Journal of Nuclear Medicine.

[15]  Fabian Kiessling,et al.  Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38) , 2011, European Radiology.

[16]  Kumar Sharma,et al.  Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.

[17]  Stephen A. Boppart,et al.  Targeted Multifunctional Multimodal Protein-Shell Microspheres as Cancer Imaging Contrast Agents , 2011, Molecular Imaging and Biology.

[18]  K. Ley,et al.  scVEGF Microbubble Ultrasound Contrast Agents: A Novel Probe for Ultrasound Molecular Imaging of Tumor Angiogenesis , 2010, Investigative radiology.

[19]  Sanjiv S Gambhir,et al.  Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). , 2010, Radiology.

[20]  J. Willmann,et al.  Molecular ultrasound imaging: current status and future directions. , 2010, Clinical radiology.

[21]  Isabelle Tardy,et al.  BR55: A Lipopeptide-Based VEGFR2-Targeted Ultrasound Contrast Agent for Molecular Imaging of Angiogenesis , 2010, Investigative radiology.

[22]  F. Kiessling,et al.  Functional and molecular ultrasound imaging: concepts and contrast agents. , 2009, Current medicinal chemistry.

[23]  Sanjiv S Gambhir,et al.  Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. , 2008, Radiology.

[24]  J. Hossack,et al.  11A-4 Molecular Imaging with Targeted Contrast Agents and High Frequency Ultrasound , 2007, 2007 IEEE Ultrasonics Symposium Proceedings.

[25]  A. Klibanov.  Ultrasound molecular imaging with targeted microbubble contrast agents , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[26]  J. Lindner,et al.  Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. , 2007, European heart journal.

[27]  J. Lindner,et al.  Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.

[28]  John A Hossack,et al.  Enhanced targeting of ultrasound contrast agents using acoustic radiation force. , 2007, Ultrasound in medicine & biology.

[29]  D. Cosgrove,et al.  WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns. , 2007, Ultrasound in medicine & biology.

[30]  Eric Tom,et al.  Myocardial Ischemic Memory Imaging With Molecular Echocardiography , 2007, Circulation.

[31]  B. Wang,et al.  Prolonging the ultrasound signal enhancement from thrombi using targeted microbubbles based on sulfur-hexafluoride-filled gas. , 2006, Academic radiology.

[32]  Damon L. Meyer,et al.  Reduced antibody response to streptavidin through site‐directed mutagenesis , 2001, Protein science : a publication of the Protein Society.

[33]  E. Ruoslahti,et al.  A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. , 2000, Cancer research.

[34]  A. Corti,et al.  The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy , 1997, European Journal of Nuclear Medicine.

[35]  I. Stamenkovic,et al.  Redirection of tumor metastasis by expression of E-selectin in vivo , 1996, The Journal of experimental medicine.

[36]  R. Cummings,et al.  The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. , 1994, The Journal of biological chemistry.

[37]  D. Devine,et al.  The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. , 1991, Journal of immunology.

[38]  W. Luboldt,et al.  Visualization of Somatostatin Receptors in Prostate Cancer and its Bone Metastases with Ga-68–DOTATOC PET/CT , 2009, Molecular Imaging and Biology.

[39]  S. Moghimi,et al.  Liposome-mediated triggering of complement cascade. , 2008, Journal of liposome research.

[40]  A. Klibanov,et al.  Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. , 2005, Bioconjugate chemistry.